Cantargia AB (publ)
SSE:CANTA.ST
Overview | Financials
Company Name | Cantargia AB (publ) |
Symbol | CANTA.ST |
Currency | SEK |
Price | 3.32 |
Market Cap | 554,400,160 |
Dividend Yield | 0% |
52-week-range | 3.202 - 8.195 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Goran Forsberg |
Website | https://www.cantargia.com |
An error occurred while fetching data.
About Cantargia AB (publ)
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as block the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD